Summary
An accelerated approval was also given for adults sixty‑five and older, allowing quicker access.
The vaccine, named mFlusiva, represents the first flu shot using messenger RNA technology.
Key Points
3 points1
First messenger RNA flu vaccine approved in the United States.
2
Traditional approval for ages 50‑64; accelerated approval for 65+.
3
Vaccine name: mFlusiva, developed by Moderna.
New Words to Learn
6 wordsUnited States Food and Drug Administration
The U.S. government agency that evaluates the safety and effectiveness of medicines.
Traditional approval
The standard, thorough review process before a medicine can be sold.
Accelerated approval
A faster review used when a medicine can help people who need it urgently.
Messenger RNA
A short strand that carries instructions from genes to make proteins, used here to teach the immune system.
Vaccine
A product that trains the body’s defenses to recognize and fight a disease.
Moderna
A company that creates medicines using messenger RNA technology.
Want to learn even more? Click here to read the full story!
🔊 Reading Article
Kid-friendly voice